Cheaper Generic Version of HIV Prevention Drug Approved

The US FDA has approved a generic version of the lenacapavir drug for HIV prevention. This makes the medication more accessible and affordable for residents in 120 countries. The new option allows for a cheaper PrEP alternative for individuals at high risk of HIV infection, administered via injection every three months.

Read the full article at Stan.kz →

Headline and summary written by daryo. The full report belongs to Stan.kz.